Autophagy appears to play an important role in the normal development and maintenance of homeostasis in a variety of tissues, including the female reproductive tract. However, the role of autophagy and the association between autophagy and apoptosis in cyclic remodeling of the human endometrium have not been described. Therefore, we investigated the involvement of autophagy during the human endometrial cycle and its association with apoptosis. Endometrial samples were obtained from 15 premenopausal, nonpregnant women who underwent hysterectomies for benign gynecological reasons. The autophagy-associated protein, microtubule-associated protein 1 light chain 3 alpha (MAP1LC3A), was immunolocalized, and its expression level was measured by Western blot analysis. Apoptosis was evaluated by measuring the expression level of cleaved caspase 3 protein. MAP1LC3A protein was primarily expressed within the endometrial glandular cells and increased during the secretory phase. The expression level of the membrane-bound form of MAP1LC3A (MAP1LC3A-II) also increased as the menstrual cycle progressed, reaching a maximum level during the late secretory phase. This pattern coincided with the expression of cleaved caspase 3. Furthermore, expression of MAP1LC3A-II and cleaved caspase 3 increased in the in vitro-cultured endometrial cancer cells when estrogen and/or progesterone were withdrawn from the culture media to mimic physiological hormonal changes. These findings suggest that endometrial cell autophagy is directly involved in the cyclic remodeling of the human endometrium and is correlated with apoptosis. In addition, we inhibited autophagic processes using 3-methyladenine (3-MA) or bafilomycin A1 (Baf A1) to evaluate the role of autophagy in apoptosis induction in endometrial cancer cells. While the inhibition of autophagosome formation using 3-MA did not decrease apoptosis or cell death, the inhibition of autophagosome degradation by fusion with lysosomes using Baf A1 increased apoptosis and cell death, suggesting that the accumulation of autophagosomes induces apoptosis. Furthermore, Baf A1-induced apoptotic cell death was decreased by the apoptosis inhibitor N-benzyloxycarbonylVal-Ala-Asp-fluoromethylketone (Z-VAD-FMK). In conclusion, these results indicate that autophagy is involved in the endometrial cell cycle affecting apoptosis and is most prominent during the late secretory phase. apoptosis, autophagy, endometrium
INTRODUCTION
The human endometrium is a dynamic tissue that undergoes monthly cyclic changes, including proliferation, differentiation, and degeneration. These sequential changes are generally regarded as being associated with ischemic necrosis of the functional layer of the endometrium caused by contraction of the spiral arteries, with the process being dependent on the concentration of sex hormones [1, 2] . In contrast to earlier findings, recent studies have detected apoptosis, a form of programmed cell death (PCD), in the endometrial epithelial cells during the late secretory phase and in the menstruating endometrium, whereas very little apoptosis has been detected during the proliferative phase or at the beginning of the secretory phase [3] [4] [5] . Therefore, apoptosis appears to be the common pathway of cell death for eliminating senescent endometrial cells from the functional layer of the human endometrium during the late secretory and menstrual phases of the cycle [6, 7] . However, apoptosis may not be the only mechanism of endometrial cell death, because nonapoptotic forms of PCD, such as autophagy (accumulation of autophagosomes), were also observed in human endometrial tissues [8, 9] .
Autophagy is an intracellular bulk degradation system in which a portion of the cytoplasm is enveloped in double membrane-bound structures called autophagosomes, which undergo maturation and fusion with lysosomes for degradation [10, 11] . Autophagy was originally thought to represent a survival response to nutrient deprivation and other forms of cellular stress [12] ; however, the results of many studies suggest that autophagy promotes cell death via excessive selfdigestion and degradation of essential cellular constituents [13] [14] [15] [16] [17] . Furthermore, previous studies have demonstrated that autophagy can be triggered by various stimuli and conditions that induce apoptosis [18] [19] [20] . In particular, two of our recent studies have reported that autophagy is directly involved in cell death and is related to apoptosis induction in granulosa and luteal cells during follicular atresia and corpus luteum regression, respectively [21, 22] . Therefore, autophagy may also be associated with endometrial cell death by apoptosis in the cyclic remodeling of the endometrium. To our knowledge, however, both the involvement and the induction of autophagy, as well as the association between autophagy and apoptosis during the human endometrial cycle, have not yet been reported. Furthermore, it is not known whether autophagy mediates apoptosis induction in endometrial cells, although previous results have suggested that autophagic processes, such as autophagosome accumulation, are crucial for the regulation of apoptotic cell death in various cell types [23] [24] [25] [26] . Therefore, we conducted the present study to determine the involvement and induction of autophagy during the human endometrial cycle, with a particular focus on endometrial cell apoptosis.
MATERIALS AND METHODS

Participants
Endometrial samples were collected from 15 premenopausal, nonpregnant women (age range, 36-47 yr) who underwent hysterectomies for benign gynecological reasons (adenomyosis, n ¼ 8; uterine myoma, n ¼ 7). The present study was approved by the Ethical Committee of the Samsung Medical Center, and written informed consent was obtained from participants. All women who participated had not taken contraceptives or hormonal agents for at least 2 mo before surgery. The day of the menstrual cycle was established from the patient's menstrual history and was verified by histological examination of the endometrium. Samples were divided into five categories according to menstrual cycle phases: early proliferative phase (Days 1-5, n ¼ 3), mid and late proliferative phase (Days 6-14, n ¼ 3), early secretory phase (Days 15-18, n ¼ 3), midsecretory phase (Days 19-23, n ¼ 3), and late secretory phase (Days 24-28, n ¼ 3). The endometrial tissue samples were obtained from the corpora lutea of the uteri and were divided into two parts. One part of each sample was immediately fixed in 10% neutral buffered formalin at 48C for 24 h, embedded in paraffin, and sectioned (thickness, 5 lm) before immunohistochemistry. The other part of the sample was snap-frozen in liquid nitrogen and stored at À808C for Western blot analysis.
Immunohistochemistry
Protein levels of microtubule-associated protein 1 light chain 3 alpha (MAP1LC3A), which is widely used as an autophagic marker, were upregulated during autophagy induction [27, 28] . In the present study, localization of MAP1LC3A with the human endometrium during the menstrual cycle was established using immunohistochemistry to determine the site of autophagy in endometrial cells.
Paraffin-embedded endometrial sections were deparaffinized in xylene and rehydrated through graded alcohols, and were then placed in a steamer for 30 min in 10 mM citric buffer for antigen retrieval. Endogenous peroxide was reduced by incubation of the sections with 3% H 2 O 2 for 30 min. Nonspecific binding was blocked with 5% bovine serum albumin (BSA; Sigma Chemical Co.) in PBS for 30 min. After several washings in phosphate-buffered saline (PBS), sections were incubated overnight at 48C with anti-MAP1LC3A rabbit polyclonal antibody (diluted 1:300; Novus Biologicals) or with cleaved caspase 3 rabbit polyclonal antibody (diluted 1:200; Cell Signaling Technology), followed by incubation with a biotinylated secondary antibody (diluted 1:2000; DAKO) for 1 h. After incubation with a streptavidin-peroxidase conjugate for 3-5 min at room temperature, antibody complexes were visualized with diaminobenzidine tetrahydrochloride chromogen. The sections were counterstained with hematoxylin, dehydrated through upgraded alcohols, and mounted. For MAP1LC3A and cleaved caspase 3, negative controls lacking primary antibody were processed on adjacent tissue sections.
Human Endometrial Ishikawa Cell Culture
Human endometrial Ishikawa cells were purchased from the American Type Culture Collection and were seeded at a concentration of 1 3 10 6 cells/ml in culture dishes made of poly-L-lysine-coated, nonfluorescent, thin-bottom glass (MatTek). The cells were incubated at 378C in 5% CO 2 in minimum essential medium (MEM) supplemented with 2 mM glutamine þ 1% non essential amino acid þ 5% fetal bovine serum (FBS; Gibco-BRL) supplemented with 10% fetal BSA, glutamine, Hepes, 100 U/ml of penicillin, and 100 mg/ml of streptomycin (Gibco-BRL). After cells reached 70%-80% confluence, cultures were treated with serum-free Earle balanced salt solution (EBSS) medium (Sigma) for serum starvation. To mimic physiological hormonal changes, endometrial Ishikawa cells were also cultured with EBSS medium before hormone treatment. After 24 h of culture, 10 nM estradiol (Sigma) and 1 lM progesterone (Sigma) were added to the cultures for 24 h and then removed 24 h before analysis.
Additionally, endometrial Ishikawa cells were cultured in EBSS medium with the addition of either 10 mM 3-methyladenine (3-MA; Sigma) or 0.1 lM bafilomycin A1 (Baf A1; Sigma) to inhibit autophagic cell death. The pancaspase inhibitor N-benzyloxycarbonyl-Val-Ala-Asp-fluoromethylketone (Z-VAD-FMK; 25 lM; CalBiochem) was also added to inhibit apoptotic cell death. Twenty-four hours later, the accumulation of autophagosomes was measured by immunofluorescence and transmission-electron microscopy. Endometrial Ishikawa cell death and apoptosis were evaluated using Trypan blue and Hoechst 33342 staining, respectively. In addition, the expression of apoptosis-related proteins was examined by Western blot analysis.
Immunofluorescence Staining
Endometrial Ishikawa cells were cultured on sterilized glass coverslips, fixed with 4% paraformaldehyde, and blocked with 0.1% BSA in PBS. Cells were incubated with anti-MAP1LC3A rabbit polyclonal antibody (diluted 1:500) and cleaved caspase 3 rabbit polyclonal antibody (diluted 1:500) in PBS and reacted with Alexa 488-and 568-conjugated secondary antibody (diluted 1:5000; Vector Laboratories). Finally, slides were mounted in mounting media (Vectashield; Vector Laboratories), and images were captured with a confocal microscope (Bio-Rad).
Transmission-Electron Microscopy
To identify autophagosomes at the ultrastructural level, endometrial Ishikawa cells were fixed with 2.5% glutaraldehyde in 0.1 M cacodylate buffer (pH 7.4) for 45 min at 48C, rinsed in cacodylate buffer, postfixed in 1% OsO 4 in cacodylate buffer, dehydrated, and embedded in Eponate. Ultrathin sections (thickness, 80 nm) were briefly contrasted with uranyl acetate and photographed with a transmission-electron microscope (Hitachi 7100).
Western Blot Analysis
During autophagy, MAP1LC3A is converted from the cytosolic form of MAP1LC3A (MAP1LC3A-I) to the membrane-bound form of MAP1LC3A (MAP1LC3A-II), after which MAP1LC3A-II then becomes localized to isolated membranes and autophagosomes [29, 30] , and the amount of MAP1LC3A-II expressed is correlated with the number of autophagosomes [28] . Therefore, the expression level of MAP1LC3A-II protein was measured with Western blot analysis to evaluate endometrial Ishikawa cell autophagy. Endometrial Ishikawa cell apoptosis was determined by measuring the expression level of cleaved caspase 3, which is believed to be the final mediator of apoptotic cell death [30] . In addition, we analyzed the expression levels of mitochondria-dependent apoptosis proteins (BAX and BCL2) to determine the apoptotic pathway involved. Collected endometrial tissues or cultured Ishikawa cells were lysed with ice-cold radioimmunoprecipitation assay buffer supplemented with a protease inhibitor cocktail (Complete Mini; Roche). To facilitate the complete solubilization of the cellular proteins, the cell lysates were incubated on ice for 30 min and then centrifuged at 13 000 3 g at 48C for 30 min. The whole-cell lysates (20 lg/lane) were separated by SDS-PAGE and transferred to a polyvinylidene difluoride membrane (BioRad). After blocking the nonspecific binding sites with 5% skim milk, the membrane was treated with rabbit polyclonal antibodies to MAP1LC3A (diluted 1:5000; Novus), caspase 3 (diluted 1:1000; Cell Signaling Technology), BAX (diluted 1:1000; Santa Cruz Biotechnology), or BCL2 (diluted 1:1000; Santa Cruz Biotechnology) overnight at 48C. The immunoreactive bands were visualized by incubation with horseradish peroxidase-conjugated goat anti-rabbit immunoglobulin G (diluted 1:5000; Santa Cruz Biotechnology) at room temperature (RT) for 1.5 h. Peroxidase activity was visualized with an enhanced chemiluminescence detection system (ECL plus Western blotting detection reagent; Amersham Pharmacia Biotech). Integrated optical intensities of the immunoreactive protein bands were quantified by imaging (Gel Doc 2000; Bio-Rad) and the analysis software Quantity One (version 4.0.3; Bio-Rad) and then normalized to bactin values.
Assessment of Human Endometrial Ishikawa Cell Death
Endometrial Ishikawa cell death was determined using the Trypan blue exclusion test (Trypan blue stains dead cells blue but does not permeate living cell membranes). A 0.4% solution of Trypan blue (Sigma) was added to 0.1 ml of a cell suspension and mixed thoroughly. The mixture was allowed to stand for 10 min at RT and then centrifuged at 500 3 g for 10 min at 48C. Supernatants were discarded, and pellets were resuspended in 0.1 ml of serumsupplemented media. A small droplet from each tube was transferred to a hemocytometer and observed under a microscope. Cells that stained blue were considered to be dead.
Assessment of Human Endometrial Ishikawa Cell Apoptosis
The percentage of apoptotic cells was determined by nuclear staining with Hoechst 33248. Endometrial Ishikawa cells were suspended in neutral-buffered formalin (10%) containing Hoechst 33248 dye (5 lg/ml; Sigma). This cell suspension was spotted onto slides and assessed for typical apoptotic nuclear CHOI ET AL. morphology (nuclear shrinkage, condensation, and fragmentation) with Hoechst dye under a fluorescence microscope (Olympus DX51 with WU filter).
Statistical Analysis
Cell death, apoptosis, and the expressions of MAP1LC3A-II, BAX, BCL2, and cleaved caspase 3 proteins are reported as the mean 6 SEM of three independent experiments. Statistical analysis was performed using ANOVA. Significant differences between the treatment groups were determined by Duncan multiple-range tests. Statistical significance was inferred at P , 0.05.
RESULTS
Localization of Autophagy in the Human Endometrium During the Menstrual Cycle
MAP1LC3A was expressed in glandular and stromal cells throughout the menstrual cycle and was localized within the cytoplasm. As shown in Figure 1 , A and B, MAP1LC3A staining in glandular and stromal cells was negative or very weakly positive in the early and late proliferative phases. In contrast, intense immunoreactivity for MAP1LC3A was detected during the secretory phase and peaked during the late secretory phase of the menstrual cycle in glandular cells, whereas MAP1LC3A immunoreactivity was weak in stromal cells (Fig. 1, C and D) .
Apoptosis and Autophagy in the Human Endometrium During the Menstrual Cycle
We determined the relationship between autophagy and apoptosis in the human endometrium during the menstrual cycle by measuring the levels of MAP1LC3A-II and cleaved caspase 3 to evaluate autophagy and apoptosis, respectively. As shown in Figure 2A , MAP1LC3A-II expression increased during the late proliferative phase compared to that in the early proliferative phase, but the difference was not significant. In contrast, MAP1LC3A-II expression in the early, mid, and late secretory endometrium was significantly higher (2.85-, 4.22-, and 5.88-fold greater, respectively) than that in the early proliferative endometrium (P , 0.05). Similarly, cleaved caspase 3 expression also increased significantly during the secretory phase, reaching a maximum during the late secretory phase (P , 0.05) (Fig. 2B) .
We also colocalized MAP1LC3A and cleaved caspase 3 in the human endometrium during the menstrual cycle. Endometrial glandular cell layers stained very weakly for the MAP1LC3A protein and also showed weak cleaved caspase 3 immunoreactivity in the proliferative endometrium (Fig. 2C,  I and II). In contrast, in the secretory phase of the menstrual cycle, glandular cell layers showed intense MAP1LC3A and cleaved caspase 3 staining (Fig. 2C, III and IV) .
Hormonal Withdrawal-Induced Autophagy in Human Endometrial Ishikawa Cells
To elucidate the effects of ovarian steroids on endometrial cell autophagy, we characterized the effects of adding and removing estrogen and progesterone on MAP1LC3A-II expression in cultured endometrial Ishikawa cells. As shown in Figure 3A , the expression level of MAP1LC3A-II increased significantly in Ishikawa cells cultured with estrogen and progesterone compared to that in Ishikawa cells cultured with estrogen alone (P , 0.05). Following the incubation with estrogen and progesterone, the removal of progesterone from the media for 24 h significantly increased the expression level of MAP1LC3A-II (P , 0.05). A similar effect on MAP1L-C3A-II expression was found following estrogen removal as well as after withdrawal of both estrogen and progesterone (P , 0.05) (Fig. 3A) . Furthermore, the expression of cleaved caspase 3 in cultured Ishikawa cells was increased significantly by the addition of progesterone and the withdrawal of both estrogen and progesterone compared to the levels in Ishikawa cells cultured with estrogen alone (P , 0.05) (Fig. 3B) .
We also examined the subcellular localization of endogenous MAP1LC3A and the expression of endogenous cleaved caspase 3 to evaluate Ishikawa cell autophagy and apoptosis using immunofluorescence staining. Figure 3C shows that endogenous MAP1LC3A and cleaved caspase 3 were easily detected as red and green fluorescence, respectively, in the cultured Ishikawa cells. In the Ishikawa cells cultured with estrogen alone, MAP1LC3A-I showed a diffuse distribution throughout the cytoplasm; however, cleaved caspase 3 stained weakly (Fig. 3C, top) . On the other hand, when punctate MAP1LC3A-II structures accumulated in the cytoplasm due to the withdrawal of estrogen and progesterone, cells showed very intense immunoreactivity for cleaved caspase 3 (Fig. 3C,  bottom) .
In addition, Figure 3D shows the transmission-electron micrographs (TEMs) of the cultured Ishikawa cells. Autophagic structures are characterized by the presence of multiple autophagosomes, which are double membranous vacuoles containing engulfed cytoplasmic materials. Some autophagosomes were evident in the Ishikawa cells cultured with estrogen alone (Fig. 3D, top) . However, the number of autophagosomes increased when both estrogen and progesterone were removed from the culture media (Fig. 3D, bottom) .
Apoptotic Cell Death of Human Endometrial Ishikawa Cells Increased with the Accumulation of Autophagosomes
The effects of autophagy on apoptotic cell death were evaluated by the inhibition or promotion of autophagosome accumulation with 3-MA or Baf A1, respectively. As shown in Figure 4A , endogenous MAP1LC3A was easily detected as green fluorescence in the cultured Ishikawa cells. The punctate MAP1LC3A-II structures were present in the cytoplasm of Ishikawa cells cultured in serum-starved conditions (Fig. 4A , left) but progressively accumulated in the cytoplasm following Baf A1 treatment (Fig. 4A, right) . Conversely, in Ishikawa cells treated with 3-MA, MAP1LC3A-I had a diffuse distribution throughout the cytoplasm (Fig. 4A, middle) . TEMs also showed the presence of autophagosomes in serum-starved Ishikawa cells (Fig. 4B, left) , but the number of autophagosomes decreased in Ishikawa cells treated with 3-MA (Fig. 4B,  middle) . In contrast, numerous autophagosomes were visible in the cytoplasm when Ishikawa cells were treated with Baf A1 (Fig. 4B, right) .
Under these conditions, we examined cell death and apoptosis using Trypan blue and Hoechst 33342 staining, respectively. The rate of Ishikawa cell death induced by serum starvation was not different from that of Ishikawa cells treated with 3-MA. However, cell death increased significantly in Ishikawa cells treated with Baf A1 compared to that in the serum-starved or 3-MA-treated Ishikawa cells (P , 0.05) (Fig.  4C) . Also, the number of Ishikawa cells with apoptotic nuclear morphology did not change following treatment with 3-MA but significantly increased following treatment with Baf A1 (P , 0.05) (Fig. 4D) . 
THE ROLE OF AUTOPHAGY IN HUMAN ENDOMETRIUM
Accumulation of Autophagosomes Increased BAX Expression and Activated Caspases
We analyzed the expression of mitochondria-dependent apoptosis proteins to determine the apoptotic pathway involved. As shown in Figure 5 , A and B, the expression levels of BAX, BCL2, and cleaved caspase 3 proteins induced by serum starvation did not change with 3-MA treatment. However, Baf A1 treatment significantly increased BAX protein expression (Fig. 5B, top) without affecting BCL2 protein expression (P , 0.05) (Fig. 5B, middle) . In addition, the expression level of cleaved caspase 3 protein in Baf A1-treated Ishikawa cells was significantly higher than that in serum-starved or 3-MA-treated Ishikawa cells (P , 0.05) (Fig.  5B, bottom) .
Finally, to confirm whether autophagosome accumulationinduced apoptotic cell death is caspase-dependent, we evaluated the effect of the caspase inhibitor Z-VAD-FMK on apoptotic cell death in endometrial Ishikawa cells with autophagosome accumulation. Ishikawa cell death and apoptosis induced by Baf A1 were significantly reduced when treated with Z-VAD-FMK (P , 0.05) (Fig. 5, C and D) .
DISCUSSION
To our knowledge, the present study is the first to examine the involvement of autophagy in the cyclic remodeling of the human endometrium during the menstrual cycle. Although the expression of autophagy-associated proteins in human endometrial tissues has been described previously [8, 9] , studies regarding the involvement of autophagy in the cyclic remodeling of the endometrium, the site of autophagy induction, and the association between autophagy and apoptosis have not yet been reported. In the present study, samples of human endometrium were immunostained for the MAP1LC3A protein to determine the site of autophagy in endometrial cells. As shown in Figure 1 , MAP1LC3A expression was negative to weakly positive in both endometrial glandular and stromal cells during the proliferative phase. In contrast, stronger staining for MAP1LC3A was observed in glandular cells during the secretory phase, whereas weak MAP1LC3A immunoreactivity was present in stromal cells. These findings suggest that autophagy occurs primarily in the glandular cells of the secretory endometrium during the menstrual cycle. This pattern is similar to the previous observation that apoptosis was detected in the glandular epithelium of the late secretory phase and menstruating endometrium, whereas very little apoptosis was detected during the proliferative phase or at the beginning of the secretory phase [3] [4] [5] . Therefore, endometrial cell autophagy may be involved in the regulation of the human endometrial cycle.
To demonstrate this hypothesis, we evaluated whether autophagy was related to apoptosis in human endometrial tissues during the menstrual cycle. In the present study, the endometrial cell autophagy, as assessed by MAP1LC3A-II level, increased as the menstrual phase progressed and reached a maximum level during the late secretory phase. In addition, the expression of cleaved caspase 3 showed the same pattern, suggesting that autophagy is closely related to endometrial cell apoptosis in the human endometrial cycle. To further confirm the relationship between endometrial cell autophagy and apoptosis, the colocalization of MAP1LC3A and cleaved caspase 3 in human endometrium was conducted. In the secretory endometrium, MAP1LC3A-positive glandular cell layers exhibited intense and aggregated cleaved caspase 3 immunoreactivity, whereas MAP1LC3A-negative glandular cell layers in the proliferative endometrium showed negative or weak cleaved capase-3 immunoreactivity (Fig. 2C) , suggesting that endometrial cell autophagy may be directly involved in the regulation of the human endometrial cycle and is closely correlated with apoptosis induction.
According to previous studies, endometrial glandular and stromal cell apoptosis during the menstrual cycle appears to be controlled by the ovarian steroids estrogen and progesterone, which represent the two central balancing factors in the human endometrium. Indeed, under the influence of estrogen, endometrial cells proliferate as a result of estrogen-induced activation of antiapoptotic genes and inhibition of proapoptotic genes. On the other hand, progesterone, the main hormone during the secretory phase, inhibits estradiol-induced cell proliferation and antiapoptotic effects in the endometrial epithelium [31] [32] [33] [34] . In the absence of implantation, a rapid decrease in these hormones induces the menstrual cascade beginning with shrinkage of the entire endometrium, which is characterized by the activation of proapoptotic factors and the induction of apoptosis [35, 36] . Similarly, our in vitro experiments show that expression of MAP1LC3A-II and cleaved caspase 3 in Ishikawa cells treated with estrogen alone (the proliferative phase) increased with the addition of progesterone (the secretory phase) and with the removal of estrogen and/or progesterone (the menstrual phase). Furthermore, our immunofluorescence results (Fig. 3C) and TEMs (Fig. 3D) provide direct evidence for the induction of autophagy corresponding to the withdrawal of both estrogen and progesterone. In addition, MAP1LC3A-II protein accumulation and ultrastructural changes in typical autophagy were visible, including the presence of multiple autophagosomes within cells. These results indicate that endometrial cell autophagy likely is regulated by ovarian steroids. The autophagy and apoptosis measured by immunofluorescent cleaved caspase 3 and MAP1LC3A-II levels appeared in the same pattern as in the Ishikawa cells (Fig. 3C) . Taken together, these results indicate that endometrial cell autophagy is primarily induced during the secretory phase and in the menstruating endometrium during the menstrual cycle, is regulated by ovarian steroids, and is closely associated with apoptosis.
A correlation between autophagy and apoptosis has previously been described for human cancer cells [23] [24] [25] [26] and ovarian cells, including granulosa cells [37] and luteal cells [22] . In these reports, the induction of apoptosis was promoted by the accumulation of autophagosomes in the cytoplasm. This finding suggests that autophagy may induce apoptotic cell death. Furthermore, apoptotic endometrial cell death may also be induced by autophagy during the human endometrial cycle. To confirm this hypothesis, we treated serum-starved endometrial Ishikawa cells with 3-MA or Baf A1 to inhibit or promote, respectively, the accumulation of autophagosomes. 3-MA inhibits the formation of autophagosomes by inhibiting the activity of class III phosophoinositide-3 kinases, which are involved in the conversion of MAP1LC3A-I to MAP1LC3A-II [38, 39] . In contrast, Baf A1 causes autophagosome accumulation by reducing the removal of autophagosomes through fusion with lysosomes, producing a cellular morphology initially consistent with autophagy [40, 41] . Indeed, our immunofluorescence and transmission-electron microscopy studies revealed that serum starvation-induced autophagosome accumulation in Ishikawa cells was decreased by 3-MA but increased by Baf A1 (Fig. 5A ). Under these conditions, the rates of cell death and apoptosis in the Baf A1-treated Ishikawa cells were significantly higher than those in Ishikawa cells CHOI ET AL. treated with 3-MA. These data indicate that the accumulation of autophagosomes induces apoptotic Ishikawa cell death. However, rates of cell death and apoptosis in Ishikawa cells treated with serum starvation alone were not higher than those of 3-MA-treated Ishikawa cells, although autophagosomes were observed to accumulate in the cytoplasm of serum-starved cells. This finding suggests that serum starvation-induced autophagosome accumulation, by itself, may not be sufficient to promote apoptotic Ishikawa cell death. Similarly, previous studies found that apoptotic cell death was promoted through the accumulation of a sufficient amount of autophagosomes and was induced by prolonged serum starvation and lysosomal inhibition in HeLa cells [25, 26] . These findings suggest that a certain level of autophagosome accumulation may be needed to promote endometrial cell death and apoptosis.
The ratio of BAX to BCL2 has been proposed as the critical determinant of apoptotic cell death, such that elevated BCL2 extends the survival of cells whereas elevated BAX expression accelerates apoptotic cell death [42, 43] . In the present study, we found that BAX expression increased without a change in BCL2 expression in Ishikawa cells with autophagosome accumulation, which suggests that the increase in the BAX:BCL2 ratio in Ishikawa cells is induced by autophagosome accumulation. In addition, the active form of caspase 3 (executioner caspase) also increased with Baf A1-induced autophagosome accumulation. Therefore, it is possible that the accumulation of autophagosomes increased Ishikawa cell apoptosis via increased BAX expression and subsequent caspase activation. Furthermore, our results indicate that autophagosome accumulation induced caspase-dependent apoptotic cell death in endometrial cells, because Baf A1-induced Ishikawa cell death was prevented by the pan-caspase inhibitor, Z-VAD-FMK. Taken together, these results suggest that autophagy likely plays an important role in the regulation of apoptotic endometrial cell death by affecting the BAX:BCL2 ratio and the subsequent activation of caspases.
In conclusion, autophagy is primarily induced in human endometrial glandular cells during the secretory phase of the menstrual cycle. Endometrial cell autophagy (accumulation of autophagosomes) induces apoptotic cell death via an increase in the BAX:BCL2 ratio followed by caspase activation.
